Detalles de la búsqueda
1.
Single-isocenter stereotactic non-coplanar arc treatment of 200 patients with brain metastases: multileaf collimator size and setup uncertainties.
Strahlenther Onkol
; 198(5): 436-447, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34528112
2.
Outcomes based on prior therapy in the phase 3 METEOR trial of cabozantinib versus everolimus in advanced renal cell carcinoma.
Br J Cancer
; 119(6): 663-669, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30197417
3.
A randomized phase II trial of interleukin-2 and interferon-α plus bevacizumab versus interleukin-2 and interferon-α in metastatic renal-cell carcinoma (mRCC): results from the Danish Renal Cancer Group (DaRenCa) study-1.
Acta Oncol
; 57(5): 589-594, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29392960
4.
A five-factor biomarker profile obtained week 4-12 of treatment for improved prognostication in metastatic renal cell carcinoma: Results from DARENCA study 2.
Acta Oncol
; 55(3): 341-8, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26449266
5.
The effect of region of interest strategies on apparent diffusion coefficient assessment in patients treated with palliative radiation therapy to brain metastases.
Acta Oncol
; 54(9): 1529-34, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26236963
6.
MR-guided stereotactic radiotherapy of infra-diaphragmatic oligometastases: Evaluation of toxicity and dosimetric parameters.
Radiother Oncol
; 192: 110090, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38224916
7.
Nivolumab With or Without Ipilimumab Combined with Stereotactic Body Radiotherapy in patients with Metastatic Biliary Tract Cancer: A Randomized Phase 2 Study.
Clin Cancer Res
; 2024 Jun 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38874506
8.
Phase 2 study of ipilimumab, nivolumab, and tocilizumab combined with stereotactic body radiotherapy in patients with refractory pancreatic cancer (TRIPLE-R).
Eur J Cancer
; 180: 125-133, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36592507
9.
Ultra-early apparent diffusion coefficient change indicates irradiation and predicts radiotherapy outcome in brain metastases.
Acta Oncol
; 56(11): 1651-1653, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28849704
10.
Online adaptive radiotherapy of urinary bladder cancer with full re-optimization to the anatomy of the day: Initial experience and dosimetric benefits.
Radiother Oncol
; 171: 37-42, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35358605
11.
Evaluation of an automated template-based treatment planning system for radiotherapy of anal, rectal and prostate cancer.
Tech Innov Patient Support Radiat Oncol
; 22: 30-36, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35464888
12.
Randomized Phase II Study of Nivolumab With or Without Ipilimumab Combined With Stereotactic Body Radiotherapy for Refractory Metastatic Pancreatic Cancer (CheckPAC).
J Clin Oncol
; 40(27): 3180-3189, 2022 09 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35476508
13.
Clinical implementation of artificial intelligence-driven cone-beam computed tomography-guided online adaptive radiotherapy in the pelvic region.
Phys Imaging Radiat Oncol
; 17: 1-7, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33898770
14.
Open-Label, Single-Arm Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Clear Cell Renal Cell Carcinoma.
J Clin Oncol
; 39(9): 1020-1028, 2021 03 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33529051
15.
Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial.
Cytotherapy
; 12(6): 721-34, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20429791
16.
The value of gynecologic cancer follow-up: evidence-based ignorance?
Int J Gynecol Cancer
; 20(8): 1307-20, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21051970
17.
Diffusion MRI outlined viable tumour volume beats GTV in intra-treatment stratification of outcome.
Radiother Oncol
; 144: 121-126, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31805516
18.
Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a randomized phase 3 clinical trial.
J Immunother Cancer
; 8(2)2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32661118
19.
Dosimetric and geometric evaluation of an open low-field magnetic resonance simulator for radiotherapy treatment planning of brain tumours.
Radiother Oncol
; 87(1): 100-9, 2008 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-18262669
20.
Repeated diffusion MRI reveals earliest time point for stratification of radiotherapy response in brain metastases.
Phys Med Biol
; 62(8): 2990-3002, 2017 04 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-28306548